TRex Bio Reports Positive Phase 1a Results for TRB-061, Supporting Treg Activation in Atopic Dermatitis TRex Bio, Inc. (TRexBio), a clinical-stage biotechnology company focused on tissue regulatory T-cell (Treg) biology…
Cardio Diagnostics Releases Updated Rural Health Report Focused on Improving Cardiovascular Care and Access Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an artificial intelligence-driven precision cardiovascular medicine company, has released an…
New Study in Neurology Highlights the Potential of Quantitative MRI Biomarkers for Assessing Muscle Changes in SBMA AMRA Medical has announced the publication of new research in Neurology demonstrating the…
BeOne Medicines Receives FDA Approval for TEVIMBRA Combination in First-Line HER2-Positive Gastroesophageal Cancer BeOne Medicines Ltd., a global oncology-focused biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA)…
McKesson to Acquire Precision Medicine Group for Approximately $2.25 Billion to Expand Oncology and Biopharma Services McKesson Corporation (NYSE: MCK) has announced a definitive agreement to acquire Precision Medicine Group,…
Lōkahi Therapeutics Begins GMP Manufacturing of LT-100 for Potential Osteoarthritis Pain Treatment Lōkahi Therapeutics Inc., a subsidiary of Glucotrack, Inc. (NASDAQ: GCTK), has announced the initiation of its initial Good…
Catalent Completes $4.7 Billion Debt Refinancing to Strengthen Financial Position and Support Long-Term Growth Catalent, Inc., a global contract development and manufacturing organization (CDMO) serving the pharmaceutical, biotechnology and healthcare…
Vyome Holdings Reports Second-Quarter 2026 Results and Highlights Progress Across Clinical Pipeline Vyome Holdings, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for immuno-inflammatory and rare diseases, has announced…
Axoft Introduces Fleuron WISE Elastomer to Enable High-Resolution Imaging in Aqueous Environments Axoft, a neurotechnology company developing advanced materials and technologies for applications at the intersection of biology and electronics,…
Pretzel Therapeutics Receives FDA Clearance to Advance PX578 Into Phase 2 Study for POLG-Mediated Mitochondrial Disease Pretzel Therapeutics, Inc., a clinical-stage biotechnology company focused on developing a new generation of…
Ivonescimab Plus Chemotherapy Phase III HARMONi Results Published in The Lancet Oncology Summit Therapeutics Inc. has announced the publication of primary analysis results from its global Phase III HARMONi clinical…
Copia Scientific and HSE•AG Partner to Expand On-Deck Nucleic Acid Quantification for Laboratory Automation Copia Scientific, a provider of laboratory automation, equipment, integration and technical service solutions, has announced a…